Home
About
Overview
Sharing Data
ORCID
Help
History (14)
Cell-free generation of the notch1 intracellular domain (NICD) and APP-CTfgamma: evidence for distinct intramembranous "gamma-secretase" activities.
IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development.
Randomized phase II trials and prostate-specific antigen endpoints in prostate cancer: much ado about nothing?
Phase I trial of paclitaxel and etoposide for recurrent ovarian carcinoma: a Gynecologic Oncology Group Study.
Laser ablation as focal therapy for prostate cancer.
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Laser ablation as focal therapy for prostate cancer.
Laser ablation as focal therapy for prostate cancer. Curr Opin Urol. 2014 May; 24(3):236-40.
View in:
PubMed
subject areas
Animals
Humans
Laser Therapy
Magnetic Resonance Imaging, Interventional
Male
Organ Sparing Treatments
Predictive Value of Tests
Prostatic Neoplasms
Surgery, Computer-Assisted
Treatment Outcome
authors with profiles
Aytekin Oto
Scott E. Eggener